Selected article for: "acute sars infection and lung function"
Author: Frija-Masson, Justine; Bancal, Catherine; Plantier, Laurent; Benzaquen, Hélène; Mangin, Laurence; Penaud, Dominique; Arnoult, Florence; Flamant, Martin; d’Ortho, Marie-Pia
Title: Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach
  • Cord-id: qhq93k1s
  • Document date: 2021_3_25
    • ID: qhq93k1s
    Snippet: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has affected millions of people worldwide, and pneumonia affects 90% of patients. This raises the possibility of millions of people with altered lung function. Few data exist to date on pulmonary function after SARS-CoV-2 infection, but alteration of diffusion capacity of CO (D(LCO)) is the most frequently described abnormality. First, we present original data on lung function at 3 months after SARS-CoV-2 infection and discus
    Document: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has affected millions of people worldwide, and pneumonia affects 90% of patients. This raises the possibility of millions of people with altered lung function. Few data exist to date on pulmonary function after SARS-CoV-2 infection, but alteration of diffusion capacity of CO (D(LCO)) is the most frequently described abnormality. First, we present original data on lung function at 3 months after SARS-CoV-2 infection and discuss the effect of using European Coal and Steel Community (ECSC) or Global Lung Function Initiative (GLI) reference equations to diagnose diffusion capacity. Second, we review existing data on D(LCO) alteration after SARS-CoV-2 infection and discuss the implication of restrictive disorder in D(LCO) alteration. Last, we discuss the pathophysiology of D(LCO) alteration and try to disentangle vascular damage and fibrosis.

    Search related documents:
    Co phrase search for related documents
    • abnormal chest and acute lung injury: 1
    • abnormal chest and acute phase: 1, 2, 3, 4
    • abnormal chest and lung capacity: 1, 2, 3, 4
    • abnormal chest and lung damage: 1
    • abnormal chest and lung diffusion capacity: 1
    • abnormal chest and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abnormal chest ct and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abnormal chest ct and acute phase: 1, 2
    • abnormal chest ct and lung capacity: 1, 2, 3, 4
    • abnormal chest ct and lung diffusion capacity: 1
    • abnormal chest ct and lung disease: 1, 2, 3, 4
    • abnormal value and lung capacity: 1
    • abnormal value and lung disease: 1
    • acute ards severity respiratory distress syndrome and lung autopsy: 1
    • acute ards severity respiratory distress syndrome and lung capacity: 1, 2
    • acute ards severity respiratory distress syndrome and lung damage: 1
    • acute ards severity respiratory distress syndrome and lung disease: 1, 2
    • acute infection and adam metallopeptidase: 1
    • acute infection and adam metallopeptidase domain: 1